Novo Nordisk Cuts Deep: A New Weight-Loss Strategy?
Update: 2025-09-10
Description
Novo Nordisk, maker of Wegovy and Ozempic, slashes 9,000 jobs worldwide! Find out why the pharmaceutical giant is making massive cuts to streamline operations, save $1.25 billion, and reinvest in the booming weight-loss drug market amid rising competition. Is this a strategic move or a sign of trouble for the Danish company and its employees?
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
